Physician profile
Marcus Dewayne Epps
NPI 1134292675
$2,124.19
in general payments reported to CMS, 2019-2025
14 companies · $288 in 2025
The $288 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $419 · 2022: $519 · 2023: $620 · 2024: $278 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $544.74 | 2022-2025 | Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan, Micra |
| Abbott Laboratories | $383.00 | 2021-2025 | Gallant, Merlin@Home, Ensite Precision |
| Boston Scientific Corporation | $316.45 | 2021-2025 | Resonate El Icd Vr, Sq-Rx Pulse Generator, General - Therapies |
| Impulse Dynamics (USA) INC. | $196.53 | 2021-2024 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $176.71 | 2022-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $93.37 | 2021-2025 | Eliquis |
| Biotronik INC. | $83.83 | 2021 | |
| Altathera Pharmaceuticals LLC | $63.23 | 2023-2024 | Sotalol Hydrochloride |
| Sanofi-Aventis U.S. LLC | $59.53 | 2021-2022 | |
| Atricure, INC. | $57.75 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Janssen Pharmaceuticals, INC | $53.95 | 2021-2022 | |
| Pfizer INC. | $42.70 | 2022-2023 | |
| Biosense Webster, INC. | $39.93 | 2025 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $12.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Epps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.